Press Enter to search · ESC to close

Macro

China’s National Medical Insurance Scheme Adds GeneSci’s Gout Drug Jinbeixin

China’s National Healthcare Security Administration on Nov. 14 published its updated list of drugs newly covered by the national medical insurance catalogue and the commercial insurance innovative drug catalogue, adding Jinbeixin (fuxinizumab), a Class 1 innovative biologic developed by GeneSci Pharmaceutical. The drug is dosed once every six months.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback